Drug profile · INN
human insulin (rdna)
ACTRAPID
human insulin (rdna) (ACTRAPID) is a insulin receptor agonist.
EMA: approved Alimentary tract and metabolism (A10) A10AB01
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — human insulin (rdna)
- Class
- Alimentary tract and metabolism (A10)
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.83
Quick answer
human insulin (rdna) (ACTRAPID) is a insulin receptor agonist.
Key facts
INN human insulin (rdna)
Brand ACTRAPID
Mechanism Insulin receptor agonist
Target Insulin receptor
Therapeutic class Alimentary tract and metabolism (A10)
ATC code A10AB01
Mechanism of action
Insulin receptor agonist
Primary target: Insulin receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is human insulin (rdna)?
human insulin (rdna) (ACTRAPID) is a insulin receptor agonist.
What is the brand name for human insulin (rdna)?
ACTRAPID is a marketed brand name for human insulin (rdna). Check FDA Drugs@FDA for the current US label holder and prescribing information.